Disease Assessment Using 3D Volume vs the Number of Lesions for Prognostication of Survival in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A comparison of two disease burden assessment methods (3D volume versus the number of lesions) for prognostication of survival in metastatic melanoma: implications for the characterization of oligometastatic disease
Int. J. Radiat. Oncol. Biol. Phys 2022 Aug 22;[EPub Ahead of Print], J Kim, JS Chang, W Sung, JS Kim, TH Kim, SH Choi, KH Kim, H Ko, HS Lee, S Jeon, SJ Shin, M Liu, R OlsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.